IN2012DN00879A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00879A IN2012DN00879A IN879DEN2012A IN2012DN00879A IN 2012DN00879 A IN2012DN00879 A IN 2012DN00879A IN 879DEN2012 A IN879DEN2012 A IN 879DEN2012A IN 2012DN00879 A IN2012DN00879 A IN 2012DN00879A
- Authority
- IN
- India
- Prior art keywords
- prt8
- prt6
- prt7
- polypeptides
- involved
- Prior art date
Links
- 101100191603 Arabidopsis thaliana PRT6 gene Proteins 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000003098 androgen Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000012512 characterization method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000004153 glucose metabolism Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 named PRT5 Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL200202A IL200202A0 (en) | 2009-08-02 | 2009-08-02 | Novel proteins |
| PCT/IL2010/000621 WO2011016026A2 (en) | 2009-08-02 | 2010-08-02 | Novel proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00879A true IN2012DN00879A (enExample) | 2015-07-10 |
Family
ID=42263570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN879DEN2012 IN2012DN00879A (enExample) | 2009-08-02 | 2010-08-02 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8647632B2 (enExample) |
| EP (2) | EP2985035A1 (enExample) |
| JP (3) | JP2013500739A (enExample) |
| KR (1) | KR101623355B1 (enExample) |
| CN (1) | CN102596247B (enExample) |
| AU (1) | AU2010280368B2 (enExample) |
| CA (1) | CA2769001C (enExample) |
| IL (3) | IL200202A0 (enExample) |
| IN (1) | IN2012DN00879A (enExample) |
| SG (2) | SG10201404735VA (enExample) |
| WO (1) | WO2011016026A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013021377A1 (en) * | 2011-08-08 | 2013-02-14 | Two To Biotech Ltd. | Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders |
| CN105916874A (zh) * | 2014-01-02 | 2016-08-31 | 两合生物科技有限公司 | 新型多肽 |
| CN104262468B (zh) * | 2014-09-28 | 2017-01-18 | 新乡医学院 | 一种葡萄糖转运蛋白抑制多肽及其制备方法、应用 |
| JP6560358B2 (ja) | 2015-03-05 | 2019-08-14 | セキスイ スペシャルティ ケミカルズ アメリカ リミテッド ライアビリティ カンパニー | Ｖｃｍ重合用ｐｖｏｈ分散剤 |
| AU2016367349B2 (en) * | 2015-12-11 | 2021-01-14 | National University Corporation Kochi University | Marker for pancreatic cancer and intraductal papillary mucinous neoplasms |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5286846A (en) | 1991-06-14 | 1994-02-15 | The Government Of The United States Of America As Represented By The Dept. Of Health And Human Services | Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides |
| US6551795B1 (en) | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
| AU2001261513A1 (en) * | 2000-05-15 | 2001-11-26 | Braswell, Glenn A. | Composition and method for increasing testosterone levels |
| AU2001269922B8 (en) | 2000-06-19 | 2005-10-27 | The Uab Research Foundation | Osteoclast secreted chemokine and uses thereof |
| AU2003900747A0 (en) | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| CA2583230A1 (en) | 2004-10-05 | 2006-04-20 | Oregon Health And Science University | Compositions and methods for treating disease |
| US20080248134A1 (en) | 2005-05-04 | 2008-10-09 | Auckland Uniservices Limited | Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof |
| EP2097538A4 (en) * | 2006-12-07 | 2011-11-30 | Switchgear Genomics | TRANSCRIPTION REAGULATION ELEMENTS OF BIOLOGICAL PATHS, TOOLS AND METHODS |
-
2009
- 2009-08-02 IL IL200202A patent/IL200202A0/en unknown
-
2010
- 2010-08-02 EP EP15182357.2A patent/EP2985035A1/en not_active Withdrawn
- 2010-08-02 US US13/387,392 patent/US8647632B2/en active Active
- 2010-08-02 EP EP10806144.1A patent/EP2461829B1/en not_active Not-in-force
- 2010-08-02 CN CN201080044688.3A patent/CN102596247B/zh not_active Expired - Fee Related
- 2010-08-02 KR KR1020127004449A patent/KR101623355B1/ko not_active Expired - Fee Related
- 2010-08-02 IN IN879DEN2012 patent/IN2012DN00879A/en unknown
- 2010-08-02 CA CA2769001A patent/CA2769001C/en not_active Expired - Fee Related
- 2010-08-02 AU AU2010280368A patent/AU2010280368B2/en not_active Ceased
- 2010-08-02 WO PCT/IL2010/000621 patent/WO2011016026A2/en not_active Ceased
- 2010-08-02 SG SG10201404735VA patent/SG10201404735VA/en unknown
- 2010-08-02 SG SG2012005070A patent/SG178097A1/en unknown
- 2010-08-02 JP JP2012523432A patent/JP2013500739A/ja active Pending
-
2012
- 2012-01-26 IL IL217758A patent/IL217758A/en not_active IP Right Cessation
-
2015
- 2015-03-11 JP JP2015047903A patent/JP5833780B2/ja not_active Expired - Fee Related
- 2015-07-23 IL IL240134A patent/IL240134A/en not_active IP Right Cessation
- 2015-08-06 JP JP2015155720A patent/JP2015212302A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG10201404735VA (en) | 2014-10-30 |
| KR20120063474A (ko) | 2012-06-15 |
| WO2011016026A3 (en) | 2011-05-26 |
| IL217758A0 (en) | 2012-03-29 |
| US8647632B2 (en) | 2014-02-11 |
| US20120121602A1 (en) | 2012-05-17 |
| AU2010280368B2 (en) | 2015-07-23 |
| KR101623355B1 (ko) | 2016-05-23 |
| IL217758A (en) | 2015-10-29 |
| AU2010280368A1 (en) | 2012-03-15 |
| HK1171672A1 (zh) | 2013-04-05 |
| SG178097A1 (en) | 2012-03-29 |
| JP2013500739A (ja) | 2013-01-10 |
| EP2461829A4 (en) | 2013-06-19 |
| EP2461829A2 (en) | 2012-06-13 |
| CN102596247A (zh) | 2012-07-18 |
| CN102596247B (zh) | 2014-08-06 |
| CA2769001C (en) | 2016-07-26 |
| IL200202A0 (en) | 2010-05-31 |
| JP5833780B2 (ja) | 2015-12-16 |
| WO2011016026A2 (en) | 2011-02-10 |
| EP2461829B1 (en) | 2016-01-06 |
| CA2769001A1 (en) | 2011-02-10 |
| JP2015212302A (ja) | 2015-11-26 |
| EP2985035A1 (en) | 2016-02-17 |
| IL240134A (en) | 2016-07-31 |
| IL240134A0 (en) | 2015-09-24 |
| JP2015157811A (ja) | 2015-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2012000167A1 (en) | Human il-23 antigen binding proteins | |
| ZA202308845B (en) | Cx3cr1-binding polypeptides | |
| CA2851316C (en) | Genes and proteins for alkanoyl-coa synthesis | |
| MY159398A (en) | Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide | |
| HK1200468A1 (en) | Anti-erbb3 antibodies and uses thereof | |
| PH12013500410B1 (en) | Vegf-binding molecules | |
| PH12012502272A1 (en) | Biological materials related to her3 | |
| MX2015008446A (es) | Composiciones de proteinas de union multivalentes. | |
| MX2016003943A (es) | Composiciones y formulaciones para la prevencion y reduccion de tumorigenesis, invasion y proliferacion de celulas de cancer y metodos de produccion y uso en el tratamiento del cancer. | |
| IN2015DN02826A (enExample) | ||
| UA111711C2 (uk) | Засіб імунотерапії деяких видів пухлин, у тому числі раку шлунково-кишкового тракту і раку шлунка | |
| NZ603271A (en) | Anti-erbb3 antibodies | |
| MX2013003681A (es) | Ácidos nucleicos manipulados y métodos de uso de los mismos. | |
| WO2011146527A3 (en) | Mammalian genes involved in infection | |
| IN2014MN01886A (enExample) | ||
| IN2012DN00879A (enExample) | ||
| WO2013003037A3 (en) | Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers | |
| WO2012122378A3 (en) | Antibody-like proteins for therapeutic and diagnostic use | |
| WO2011085134A8 (en) | Methods and compositions for the diagnosis, prognosis and treatment of cancer | |
| WO2009146463A3 (en) | Variant hhip1 protein and methods and uses thereof | |
| WO2011005523A3 (en) | Galectin-immunoglobulin chimeric molecules | |
| GB0818080D0 (en) | Immunogenic peptides | |
| WO2011031833A3 (en) | Human anti-cancer antibodies | |
| WO2010100437A3 (en) | Production of protein | |
| HK1226254A1 (en) | Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment |